Abstract
Background
The relationship between the location of the primary tumor and survival of adenosquamous carcinoma (ASC) remains poorly understood. This study aimed to evaluate the impact of primary tumor location on the survival outcome of patients with ASC.
Methods
Patients with ASC were extracted from the Surveillance, Epidemiology, and End Results (SEER) database with ≥ 150 cases per tumor location. The Kaplan–Meier method was used to generate survival curves and differences among them were compared using the log-rank test. On the other hand, Cox proportional hazards models were used to evaluate factors that had independent predictive effects on cancer-specific survival (CSS).
Results
A total of 14,829 eligible patients with ASC were included in this study. Lung and bronchus ASC accounted for 51.1%, followed by the cervix uteri (17.0%), corpus uteri (13.9%), pancreas (4.9%), esophagus (3.1%), gallbladder (2.5%), stomach (2.2%), colon and rectum (2.0%), head and neck (1.8%), and breast ASC (1.3%). The 5-year CSS of breast, cervix uteri, colon and rectum, corpus uteri, esophagus, gallbladder, head and neck, lung and bronchus, pancreas, and stomach ASC was 76.9%, 66.0%, 34.8%, 72.9%, 12.0%, 10.8%, 45.0%, 24.7%, 4.3%, and 17.3%, respectively. COX analysis demonstrated that the primary tumor location was an independent prognostic factor for CSS. Besides, the breast, uterine corpus, and cervix as well as head and neck ASC were significantly associated with better prognosis, while pancreas and gallbladder ASC were significantly associated with poor CSS; stomach and colorectal were roughly the same as ASC prognosis.
Conclusion
Our study showed that the CSS of patients with ASC depends on the location of the primary tumor. Besides, tumor location is an important factor that should guide the use of chemotherapy and radiation.
Similar content being viewed by others
Data availability
All data generated or analyzed in this study was derived from the SEER database and can be obtained through the inclusion and exclusion criteria in this article.
References
Shi X, Shao X, Zhang Y, Wu F, Tao Y (2020) Tumor location and survival outcomes in lung adenosquamous carcinoma: a propensity score matched analysis. Med Sci Monit 26:e922138
Filosso PL, Ruffini E, Asioli S, Giobbe R, Macri L, Bruna MC, Sandri A, Oliaro A (2011) Adenosquamous lung carcinomas: a histologic subtype with poor prognosis. Lung Cancer 74(1):25–29
Li C, Lu H (2018) Adenosquamous carcinoma of the lung. Onco Targets Ther 11:4829–4835
Wu X, Yu W, Petersen RH, Sheng H, Wang Y, Lv W, Hu J (2020) A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma. BMC Cancer 20(1):429
Zhou SY, Qiao ZG, Li CL, Chen TB (2020) Primary adenosquamous carcinoma of the liver. Kaohsiung J Med Sci 36(10):857–858
Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ Jr, Yopp AC (2020) Comparative outcomes of adenosquamous carcinoma of the gallbladder: an analysis of the National Cancer Database. J Gastrointest Surg 25(7):1815–1827
Ren S, Zhao R, Cui W, Qiu W, Guo K, Cao Y, Duan S, Wang Z, Chen R (2020) Computed tomography-based radiomics signature for the preoperative differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Front Oncol 10:1618
Nasseri Y, Cox B, Shen W, Zhu R, Stettler I, Cohen J, Artinyan A, Gangi A (2020) Adenosquamous carcinoma: an aggressive histologic sub-type of colon cancer with poor prognosis. Am J Surg 221(3):649–653
Cheung R (2016) Analysis of SEER adenosquamous carcinoma data to identify cause specific survival predictors and socioeconomic disparities. Asian Pac J Cancer Prev 17(1):347–352
Wang CB, Shahjehan F, Merchea A, Li Z, Bekaii-Saab TS, Grothey A, Colibaseanu DT, Kasi PM (2019) Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: a Mayo Clinic Colon and Rectal Cancer Registry Study. Front Oncol 9:76
Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T (2015) Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg 261(4):733–739
Wu SG, Chen XT, Zhang WW, Sun JY, Li FY, He ZY, Pei XQ, Lin Q (2018) Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis. Expert Rev Gastroenterol Hepatol 12(2):209–214
Wang J, Lian B, Ye L, Hu J, Song Y (2018) Clinicopathological characteristics and survival outcomes in adenosquamous carcinoma of the lung: a population-based study from the SEER database. Oncotarget 9(8):8133–8146
Ge Y, Lin L, Ma X, Luo D, Shi L, Jiang M, Fan H, He Y, Yang L, Xu Z (2019) Adenosquamous carcinoma of the stomach: a population-based study from the SEER database. J Cancer 10(23):5705–5713
Fang Y, Pu N, Zhang L, Wu W, Lou W (2019) Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database. Ann Transl Med 7(20):522
Duorui N, Shi B, Zhang T, Chen C, Fang C, Yue Z, Wu P, Wu Z, Huang X, Li M (2020) The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: a population-based study. PLoS ONE 15(12):e0243164
Hu M, Zhang B, Xu J, Wang S, Zhao Y, Zhang L, Han B (2019) Clinical outcomes of different generations of EGFR tyrosine kinase inhibitors in advanced lung adenosquamous carcinoma. Mol Diagn Ther 23(6):773–779
Lee RJ, Lin T, Lee SA, Lee KK, Christensen RE (2017) Importance of tumor extent in adenosquamous carcinoma of the head and neck: a retrospective cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol 124(2):114–120
Qin BD, Jiao XD, Yuan LY, Liu K, Zang YS (2018) Adenosquamous carcinoma of the bile duct: a population-based study. Cancer Manag Res 10:439–446
Mengoli MC, Longo FR, Fraggetta F, Cavazza A, Dubini A, Ali G, Guddo F, Gilioli E, Bogina G, Nannini N (2018) The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 Classification. Pathologica 110(1):39–67
Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS (2012) 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res 174(1):12–19
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509–W514
Hoshimoto S, Hoshi S, Hishinuma S, Tomikawa M, Shirakawa H, Ozawa I, Wakamatsu S, Hoshi N, Hirabayashi K, Ogata Y (2017) Adenosquamous carcinoma in the biliary tract: association of the proliferative ability of the squamous component with its proportion and tumor progression. Scand J Gastroenterol 52(4):425–430
Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, Hershman DL, Wright JD (2012) Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 125(2):287–291
Lai CH, Lau WY (2008) Gallbladder cancer–a comprehensive review. Surgeon 6(2):101–110
Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: a population-based study. PLoS ONE 13(6):e0198809
Chen YY, Li AF, Huang KH, Lan YT, Chen MH, Chao Y, Lo SS, Wu CW, Shyr YM, Fang WL (2015) Adenosquamous carcinoma of the stomach and review of the literature. Pathol Oncol Res 21(3):547–551
Schizas D, Kapsampelis P, Mylonas KM (2018) Adenosquamous carcinoma of the esophagus: a literature review. J Transl Int Med 6(2):70–73
Toumi O, Hamida B, Njima M, Bouchrika A, Ammar H, Daldoul A, Zaied S, Ben Jabra S, Gupta R, Noomen F (2018) Adenosquamous carcinoma of the right colon: a case report and review of the literature. Int J Surg Case Rep 50:119–121
Chen H, Shen C, Yin R, Yin Y, Chen J, Han L, Zhang B, Chen Z, Chen J (2015) Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma. World J Surg Oncol 13:136
Evans M, Liu Y, Chen C, Steuer C, Cassidy R III, Landry J, Higgins K, Beitler JJ, Willingham F, Owonikoko TK (2017) Adenosquamous carcinoma of the esophagus: an NCDB-based investigation on comparative features and overall survival in a rare tumor. Oncology 93(5):336–342
Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA (2011) Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg 15(1):165–174
Author information
Authors and Affiliations
Contributions
Chuang Cheng conceived and designed the study; Zan Luo and Wei Xiong performed the analysis; Hui Tan and Zhongquan Shi prepared the figures and tables. All authors analyzed the results, wrote the main manuscript, and reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics approval
Due to the absence of patient identifiers, approval from the Institutional Review Board was not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cheng, C., Luo, Z., Xiong, W. et al. Epidemiology and survival outcomes in adenosquamous carcinoma: a population-based study. Int J Colorectal Dis 37, 1581–1592 (2022). https://doi.org/10.1007/s00384-022-04198-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-022-04198-4